Benzinga | Mar 11, 2021 04:27PM EST

Evoke Pharma Q4 EPS $(0.09) Beats $(0.13) Estimate

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.13) by 30.77 percent. This is a 50 percent decrease over losses of $(0.06) per share from the same period last year.